AbbVie stock gains after guidance boost (NYSE:ABBV)
AbbVie (NYSE:ABBV) shares gained premarket after the pharmaceutical company raised its profit outlook for full year ...
Read moreTag: NYSEABBV
U.K. pharma lobby urges govt. to halt plans to raise revenue recovery rates (NYSE:ABBV)
FotografiaBasica/E+ via Getty Images A trade group representing the pharma industry pressed the U.K. government on ...
Read more
AbbVie, Vertex, Genmab amongst correct biotech picks at SA for 2022 (NYSE:ABBV)
Panuwat Dangsungnoen/iStock by way of Getty Pictures Searching for Contributors urged traders to purchase AbbVie (NYSE:ABBV), ...
Read more
Get the latest news and follow the coverage of Financial News, Stocks, Analysis, Trading Updates and more from the top trusted sources.